300
Participants
Start Date
March 9, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
September 30, 2029
Tacrolimus Pill
Envarsus tablets dosed to achieve and maintain whole blood trough levels of tacrolimus within a therapeutic range of 5-12 ng/ml during the first 4 weeks post-transplantation, and 5-8 ng/ml thereafter.
Tacrolimus capsule
Advagraf capsules dosed to achieve and maintain whole blood trough levels of tacrolimus within a therapeutic range of 5-12 ng/ml during the first 4 weeks post-transplantation, and 5-8 ng/ml thereafter.
NOT_YET_RECRUITING
Charité Universitätsmedizin, Department of Nephrology and Medical Intensive Care, Berlin
RECRUITING
University Medical Center Hamburg-Eppendorf, Internal Medicine III (Nephrology, Rheumatology, Endocrinology), Hamburg
RECRUITING
Hannover Medical School, Department of General, Visceral and Transplant Surgery, Hanover
NOT_YET_RECRUITING
University Hospital Münster, Medical Clinic D, Münster
NOT_YET_RECRUITING
University Hospital Aachen, Department of General, Visceral and Transplant Surgery, Aachen
NOT_YET_RECRUITING
University Medical Center of the Johannes Gutenberg University Mainz, Medical Clinic I. (Nephrology), Mainz
RECRUITING
University Hospital Regensburg, Department of Nephrology, Regensburg
RECRUITING
University Hospital Dresden, Division of Nephrology, Dresden
RECRUITING
University Hospital Jena, Internal Medicine III, Nephrology, Jena
Collaborators (1)
Chiesi Pharmaceuticals GmbH
INDUSTRY
Edward Geissler
OTHER